StockMarketWire.com - OptiBiotix Health said subsidiary ProBiotix Health had signed a license agreement with Instituto Espanol de Nutricion Personalizada.

The agreement was for the use of the company's Lactobacillus plantarum strain in personalised food supplements in Spain.

It granted IENP non-exclusive rights to manufacture and market food supplements containing the strain in Spain for a period of three years.


At 9:38am: [LON:OPTI] Optibiotix Health Plc share price was -0.1p at 76.5p



Story provided by StockMarketWire.com